Hepacivirus Concept

Vocabulary Service

MeSH

Overview

subject area of

5-(Perylen-3-yl)Ethynyl-arabino-Uridine (aUY11), an Arabino-Based Rigid Amphipathic Fusion Inhibitor, Targets Virion Envelope Lipids To Inhibit Fusion of Influenza Virus, Hepatitis C Virus, and Other Enveloped Viruses Academic Article
A randomized study of alpha-interferon plus ribavirin for 6 months or 12 months for the treatment of chronic hepatitis C in patients with bleeding disorders Academic Article
Antibodies against Hepatitis C in a Population of Swedish Haemophiliacs and Heterosexual Partners Academic Article
Biological and clinicopathological features associated with hepatitis C virus type 5 infections Academic Article
Class A Scavenger Receptor–Mediated Double-Stranded RNA Internalization Is Independent of Innate Antiviral Signaling and Does Not Require Phosphatidylinositol 3-Kinase Activity Academic Article
Clinical trial: exposure to ribavirin predicts EVR and SVR in patients with HCV genotype 1 infection treated with peginterferon alfa-2a plus ribavirin Academic Article
Co-Infection by Hepatitis C Virus in HIV-Infected Patients in Southern Brazil: Genotype Distribution and Clinical Correlates Academic Article
Cost-effectiveness of daclatasvir plus sofosbuvir-based regimen for treatment of hepatitis C virus genotype 3 infection in Canada Academic Article
Direct-acting antiviral therapies for hepatitis C genotype 1 infection: a multiple treatment comparison meta-analysis Academic Article
Distribution of hepatitis C virus genotypes among hemodialysis patients in Tehran—a multicenter study Academic Article
Efficacy and safety of a two‐drug direct‐acting antiviral agent regimen ruzasvir 180 mg and uprifosbuvir 450 mg for 12 weeks in adults with chronic hepatitis C virus genotype 1, 2, 3, 4, 5 or 6 Academic Article
Eradication of Hepatitis C Virus Infection and the Development of Hepatocellular Carcinoma Academic Article
Favourable IFNL3 Genotypes Are Associated with Spontaneous Clearance and Are Differentially Distributed in Aboriginals in Canadian HIV-Hepatitis C Co-Infected Individuals Academic Article
Global real‐world evidence of sofosbuvir/velpatasvir as simple, effective HCV treatment: Analysis of 5552 patients from 12 cohorts Academic Article
Hepatitis C Virus-infected, HCV-RNA-negative Patients with Bleeding Disorders - Relationship to Age, HIV and Treatment Academic Article
Hepatitis C co-infection is associated with an increased risk of incident chronic kidney disease in HIV-infected patients initiating combination antiretroviral therapy Academic Article
Hepatitis C genotypes in Australian haemophilia patients Academic Article
Hepatitis C virus infection characteristics and treatment outcomes in Canadian immigrants Academic Article
IL-15 and IFN-γ signal through the ERK pathway to inhibit HCV replication, independent of type I IFN signaling Academic Article
Identification of a Novel Hepatitis C Virus Genotype From Punjab, India: Expanding Classification of Hepatitis C Virus Into 8 Genotypes Academic Article
Identification of numerous hepatitis C virus genotypes in Montreal, Canada Academic Article
Ledipasvir-Sofosbuvir Plus Ribavirin in Treatment-Naive Patients With Hepatitis C Virus Genotype 3 Infection: An Open-Label Study Academic Article
Long Term Follow-Up of Patients with Chronic Hepatitis C Treated with Alpha Interferon Academic Article
Low levels of hepatitis C diagnosis and testing uptake among people who inject image and performance enhancing drugs in England and Wales, 2012-15 Academic Article
Marijuana Use in Hepatitis C Infection does not Affect Liver Biopsy Histology or Treatment Outcomes Academic Article
Network meta-analysis of direct-acting antivirals in combination with peginterferon–ribavirin for previously untreated patients with hepatitis C genotype 1 infection Academic Article
Occult hepatitis B virus infection in the setting of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection: Clinically relevant or a diagnostic problem? Academic Article
Oral prostaglandin (PGE2) therapy for chronic viral hepatitis B and C Academic Article
Outcomes of Chronic Hepatitis C Therapy in Patients Treated in Community Versus Academic Centres in Canada: Final Results of APPROACH (A Prospective Study of Peginterferon alfa-2a and Ribavirin at Academic and Community Centres in Canada) Academic Article
Prevalence of Hepatitis C Virus Infection in a Surgical Population of Southeast China: A Large-Scale Multicenter Study Academic Article
Prevalence of hepatitis C infection in Hong Kong Academic Article
Prevalence of insulin resistance in chronic hepatitis C genotype 1 and 3 patients Academic Article
Proceedings of a consensus conference: Blood-borne HIV and hepatitis—Optimizing the donor selection process† Academic Article
Real-world effectiveness of peginterferon α-2b plus ribavirin in a Canadian cohort of treatment-naïve chronic hepatitis C patients with genotypes 2 or 3: results of the PoWer and RediPEN studies Academic Article
Recommendations for the identification of chronic hepatitis C virus (HCV) infection among persons born during 1945 through 1965 Academic Article
Replacement therapy with recombinant factor IX. A multicentre evaluation of current dosing practices in Italy. Academic Article
Replication of Subgenomic Hepatitis C Virus Replicons in Mouse Fibroblasts Is Facilitated by Deletion of Interferon Regulatory Factor 3 and Expression of Liver-Specific MicroRNA 122 Academic Article
Risk of cardiovascular disease associated with HCV and HBV co-infection among antiretroviral-treated HIV-infected individuals Academic Article
Salvage Therapy with Sofosbuvir/Velpatasvir/Voxilaprevir in DAA-experienced Patients: Results from a Prospective Canadian Registry Academic Article
Sofosbuvir/velpatasvir for 12 weeks in hepatitis C virus-infected patients with end-stage renal disease undergoing dialysis Academic Article
Targeted hepatitis C antibody testing interventions: a systematic review and meta-analysis Academic Article
The generation of a simian adenoviral vectored HCV vaccine encoding genetically conserved gene segments to target multiple HCV genotypes Academic Article
Transmission of hepatitis C with pasteurised factor VIII Academic Article
Treatment responses in Asians and Caucasians with chronic hepatitis C infection Academic Article